1-4 of 4
observation in research
Close
Sort by
Journal Articles

Subgroup Analysis of US Patients in Preamble, an Ongoing Multinational Observational Study in Multiple Myeloma

Ravi Vij, MD MBA, Surhud Khare, Samuel Perez, Sergey Popov, Clara Chen
Journal: Blood
Blood (2016) 128 (22): 2362.
https://doi.org/10.1182/blood.V128.22.2362.2362
Published: 2016
Journal Articles

An Ongoing, Observational Cohort Study in Multiple Myeloma (PREAMBLE): Preliminary Efficacy Analyses in Patients with 1 Line of Prior Therapy

Brian Durie, MD, David J Kuter, MD DPhil, Catherine Davis, Teresa Zyczynski, PharmD, MPH, MBA, BSPharm, Hartmut Goldschmidt, Ravi Vij, Sergey Popov, David Cella, PhD, Gordon Cook, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2403.
https://doi.org/10.1182/blood.V128.22.2403.2403
Published: 2016
Journal Articles

An Ongoing Multinational Observational Study in Multiple Myeloma (PREAMBLE): Preliminary Report on Patient Survival

Gordon Cook, MD PhD, David Cella, PhD, Brian Durie, MD, Hartmut Goldschmidt, MD, David Kuter, MD DPhil, Philippe Moreau, Ravi Vij, MD MBBS, Catherine Davis, Abderrahim Oukessou, Teresa Zyczynski, PharmD, MPH, MBA, BSPharm, Sergey Popov, Antonio Palumbo, MD
Journal: Blood
Blood (2015) 126 (23): 2093.
https://doi.org/10.1182/blood.V126.23.2093.2093
Published: 2015
Journal Articles

An Ongoing Multinational Observational Study in Multiple Myeloma (PREAMBLE): Initial Assessment of Treatment Patterns in Patients with ≥6 Months Follow-up

Ravi Vij, MD, Lieven Annemans, PhD, Catherine Davis, Pharm.D., Trong K. Le, MPH, MS, Blake Bartlett, PhD, Philippe Moreau, MD
Journal: Blood
Blood (2014) 124 (21): 1297.
https://doi.org/10.1182/blood.V124.21.1297.1297
Published: 2014